4004:TSEResonac Holdings Corporation Analysis
Data as of 2026-06-18 - not real-time
¥18,420.00
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Resonac Holdings is trading well above its 20‑day moving average, which itself sits above the 50‑day average, underscoring a bullish price momentum. The 14‑day RSI sits in the mid‑50s, indicating neither overbought nor oversold conditions. However, the MACD line remains below its signal line, producing a bearish histogram that warns of potential short‑term weakness. Volume trends are declining, suggesting waning buying interest despite the overall bullish trend direction. The stock’s valuation metrics are extreme, with a trailing P/E well above one hundred and a price‑to‑book multiple approaching five, pointing to an overvalued market price. Analyst consensus remains positive, with a “buy” rating and a modest upside potential of roughly seven percent.
The company’s fundamentals show a revenue contraction and thin profit margins, while debt levels dwarf equity, raising concerns about financial resilience. Dividend yield is low and the payout ratio, though below fifty percent, sits on a balance sheet burdened by high leverage. Volatility is elevated, with a 30‑day swing exceeding seventy percent and a beta above one, indicating sensitivity to market moves. Sector‑specific risks include cyclical demand in chemicals and heightened regulatory scrutiny on environmental matters. Geographic exposure is concentrated in Japan, adding a medium‑level country risk. Given these mixed signals, investors should weigh the bullish technical backdrop against the substantial valuation and risk considerations.
The company’s fundamentals show a revenue contraction and thin profit margins, while debt levels dwarf equity, raising concerns about financial resilience. Dividend yield is low and the payout ratio, though below fifty percent, sits on a balance sheet burdened by high leverage. Volatility is elevated, with a 30‑day swing exceeding seventy percent and a beta above one, indicating sensitivity to market moves. Sector‑specific risks include cyclical demand in chemicals and heightened regulatory scrutiny on environmental matters. Geographic exposure is concentrated in Japan, adding a medium‑level country risk. Given these mixed signals, investors should weigh the bullish technical backdrop against the substantial valuation and risk considerations.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- bearish MACD crossover
- decreasing volume
- price approaching resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- bullish SMA alignment
- analyst consensus buy
- potential upside to target price
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- high valuation multiples
- elevated debt‑to‑equity
- persistent volatility
Key Metrics & Analysis
Financial Health
Revenue Growth-4.10%
Profit Margin2.67%
P/E Ratio114.4
ROE5.47%
ROA1.63%
Debt/Equity130.53
P/B Ratio4.7
Technical Analysis
TrendBullish
RSI57.7
Support¥14,505.00
Resistance¥20,195.00
MA 20¥17,889.75
MA 50¥15,926.70
MA 200¥9,435.03
MACDBearish
VolumeDecreasing
Fear & Greed Index91.46
Valuation
Target Price¥19,741.67
Upside/Downside7.18%
GradeOvervalued
TypeValue
Dividend Yield0.36%
Risk Assessment
Beta1.11
Volatility75.63%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.